Family Medicine · Kaysville, UT
NPI
1104987916
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
120 S Main St
Kaysville, UT, 84037
Phone (801) 544-4227
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
316 services
Medicare patients, 2024
67
Average age 71
Drug cost, 2024
$5.9M
34,282 prescriptions
Company payments, 2025
$1,517
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Layne K Kamalu was code 99214 (office e&m - established), 201 times for 54 patients. In total Layne K Kamalu billed 316 services in 15 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 201 | 54 | $74.85 | $15K |
| 99213 Office E&M - Established | Office | 44 | 23 | $58.38 | $2,569 |
| 36415 Venipuncture Blood Collection | Office | 28 | 25 | $4.90 | $137 |
| 80305 Drug Tests | Office | 19 | 12 | $10.40 | $198 |
By year: 2022 $27K for 434 services; 2023 $26K for 403 services; 2024 $20K for 316 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 25 | $4.90 | $137 |
| 80305 Drug Tests | 19 | 12 | $10.40 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Layne K Kamalu prescribed most often to Medicare patients was Shingrix (Varicella-Zoster Ge/As01b/Pf), with 12,467 prescriptions and refills. In total Layne K Kamalu wrote 34,282 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 12,467 | 12,484 | 9,373 | $2.1M |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 8,077 | 8,103 | 8,048 | $1.9M |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 4,703 | 4,709 | 4,694 | $1.2M |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 4,102 | 4,102 | 4,089 | $222K |
| Twinrix Hepatitis A And B Vaccine/Pf | 2,406 | 2,406 | 1,622 | $274K |
| Adacel Tdap Diph,pertuss(Acell),tet Vac/Pf | 986 | 986 | 983 | $52K |
| Havrix Hepatitis A Virus Vaccine/Pf | 192 | 192 | 169 | $17K |
| M-M-R Ii Vaccine Measles,mumps,rubella Vacc/Pf | 86 | 86 | 75 | $7,981 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 58 | 58 | Under 11 | $4,819 |
| Zolpidem Tartrate Generic | 56 | 56 | Under 11 | $250 |
| Menquadfi Mening Vac A,c,y,w135,c-Tet/Pf | 51 | 51 | 51 | $7,423 |
| Simvastatin Generic | 46 | 135 | 13 | $578 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 41 | 123 | 13 | $358 |
| Alprazolam Generic | 40 | 40 | Under 11 | $528 |
| Metformin Hcl Generic | 38 | 113 | 14 | $559 |
Brand drugs: 33,321 claims; generic drugs: 943 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Layne K Kamalu $1,517 ($1,517 in general payments such as food, travel and fees) from 12 companies. The largest payer was Cardinal Health 110 LLC with $1,000.
| Company | Payments | Amount |
|---|---|---|
| Cardinal Health 110 LLC | 2 | $1,000 |
| Indivior Inc. INDV | 11 | $234 |
| Exact Sciences Corporation EXAS | 4 | $69.59 |
| Abbvie Inc. ABBV | 2 | $46.93 |
| Braeburn Inc. | 2 | $40.72 |
| Biogen, Inc. BIIB | 1 | $20.69 |
| Dexcom, Inc. DXCM | 1 | $19.6 |
| Inspire Medical Systems, Inc. INSP | 1 | $19.16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17.88 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $17.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.